Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    biederman
Show Display Options
Rank Status Study
21 Completed A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder
Condition: ADHD
Intervention: Drug: galantamine HBr
22 Completed Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: NRP104
23 Withdrawn Memantine Monotherapy for Executive Dysfunction and ADHD
Conditions: ADHD;   Executive Function Deficits (EFD's)
Interventions: Drug: Memantine;   Drug: Placebo
24 Completed
Has Results
Strattera Treatment in Adults With Attention Deficit Hyperactivity Disorder Not Otherwise Specified (ADHD NOS)
Condition: ADHD NOS
Intervention: Drug: Strattera (atomoxetine)
25 Completed
Has Results
An Open-label Study of NRP104 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity;   Attention Deficit Hyperactivity Disorders
Intervention: Drug: Vyvanse (lisdexamfetamine dimesylate), NRP104
26 Completed NRP104, Adderall XR or Placebo in Children Aged 6-12 Years With ADHD
Condition: Attention Deficit Disorder With Hyperactivity
Interventions: Drug: NRP104;   Drug: Adderall XR;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-26) Next Page   
Study has passed its completion date and status has not been verified in more than two years.